ResMed Statistics
Total Valuation
ResMed has a market cap or net worth of 36.04 billion. The enterprise value is 35.50 billion.
| Market Cap | 36.04B |
| Enterprise Value | 35.50B |
Important Dates
The last earnings date was Thursday, October 30, 2025.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.28% |
| Shares Change (QoQ) | -0.09% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 69.01% |
| Float | 145.01M |
Valuation Ratios
The trailing PE ratio is 25.06 and the forward PE ratio is 22.11.
| PE Ratio | 25.06 |
| Forward PE | 22.11 |
| PS Ratio | 6.85 |
| PB Ratio | 5.89 |
| P/TBV Ratio | 13.70 |
| P/FCF Ratio | 20.38 |
| P/OCF Ratio | 19.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.92, with an EV/FCF ratio of 20.07.
| EV / Earnings | 24.69 |
| EV / Sales | 6.75 |
| EV / EBITDA | 17.92 |
| EV / EBIT | 20.09 |
| EV / FCF | 20.07 |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.14.
| Current Ratio | 2.89 |
| Quick Ratio | 1.87 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | 0.43 |
| Debt / FCF | 0.48 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 25.41% and return on invested capital (ROIC) is 16.93%.
| Return on Equity (ROE) | 25.41% |
| Return on Assets (ROA) | 14.18% |
| Return on Invested Capital (ROIC) | 16.93% |
| Return on Capital Employed (ROCE) | 24.99% |
| Revenue Per Employee | 495,981 |
| Profits Per Employee | 135,651 |
| Employee Count | 10,600 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 2.03 |
Taxes
In the past 12 months, ResMed has paid 302.96 million in taxes.
| Income Tax | 302.96M |
| Effective Tax Rate | 17.40% |
Stock Price Statistics
The stock price has increased by +46.05% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +46.05% |
| 50-Day Moving Average | 23.21 |
| 200-Day Moving Average | 24.57 |
| Relative Strength Index (RSI) | 58.43 |
| Average Volume (20 Days) | 40,395 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 8.86 |
Income Statement
In the last 12 months, ResMed had revenue of 5.26 billion and earned 1.44 billion in profits. Earnings per share was 9.77.
| Revenue | 5.26B |
| Gross Profit | 3.19B |
| Operating Income | 1.76B |
| Pretax Income | 1.74B |
| Net Income | 1.44B |
| EBITDA | 1.94B |
| EBIT | 1.76B |
| Earnings Per Share (EPS) | 9.77 |
Balance Sheet
The company has 1.38 billion in cash and 846.35 million in debt, giving a net cash position of 537.50 million.
| Cash & Cash Equivalents | 1.38B |
| Total Debt | 846.35M |
| Net Cash | 537.50M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 6.12B |
| Book Value Per Share | 41.94 |
| Working Capital | 2.37B |
Cash Flow
In the last 12 months, operating cash flow was 1.88 billion and capital expenditures -114.99 million, giving a free cash flow of 1.77 billion.
| Operating Cash Flow | 1.88B |
| Capital Expenditures | -114.99M |
| Free Cash Flow | 1.77B |
| FCF Per Share | n/a |
Margins
Gross margin is 60.69%, with operating and profit margins of 33.52% and 27.35%.
| Gross Margin | 60.69% |
| Operating Margin | 33.52% |
| Pretax Margin | 33.11% |
| Profit Margin | 27.35% |
| EBITDA Margin | 36.87% |
| EBIT Margin | 33.52% |
| FCF Margin | 33.64% |
Dividends & Yields
ResMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 22.31% |
| Buyback Yield | 0.28% |
| Shareholder Yield | 0.28% |
| Earnings Yield | 3.99% |
| FCF Yield | 4.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ResMed has an Altman Z-Score of 12.67 and a Piotroski F-Score of 6.
| Altman Z-Score | 12.67 |
| Piotroski F-Score | 6 |